Biogen-Idec Earnings Preview (BIIB, DNA)
On Wednesday, we’ll get to see earnings out of Biogen Idec Inc. (NASDAQ: BIIB). The estimates from First Call for the biotech company are $0.80 EPS on $835.16 million in ...Read Full Story »
Posts related to ‘Rituxan’
Read Full Story »
Can Genentech Buck Its Long-Term Slide? (DNA, BIIB, NVS, OSIP, AMGN, BBH)
Genentech (NYSE: DNA) is set to report earnings after the close today. First Call has estimates pegged at $0.67 EPS on revenues of $2.97 Billion. This will also mark the ...Read Full Story »
Genentech To Set Biotech Sector Earnings Bias (DNA)
Genentech Inc. (NYSE:DNA) is set to report earnings after today's close. First Call has consensus estimates at $0.72 EPS on $2.93 Billion in revenues. The biotech giant usually offers guidance ...Read Full Story »
-
Categories:
- 24/7 Wall St. Wire (3376)
- Accounting (283)
- Activist Investor (250)
- ADR (534)
- Aerospace (111)
- After-Hours Activity (98)
- Agriculture (260)
- Airlines (303)
- Analyst Calls (2698)
- Annual Report (63)
- Apparel (208)
- Austerity (33)
- auto (15)
- Autos (1162)
- Bait Shop (91)
- Banking (1663)
- Bankruptcy (202)
- Biotech (726)
- Blogs (5)
- Bonds (384)
- Brokerage Firms (437)
- Buffett (301)
- Buffett Holdings (31)
- business and finance (27)
- Business Services (177)
- Cable Companies (128)
- Calendar (226)
- Casinos (67)
- Charts (107)
- China (857)
- Commodities (636)
- Compensation (309)
- Conglomerates (424)
- Consumer Electronics (1098)
- Consumer Goods (502)
- Corporate Governance (491)
- Cramer (728)
- Cult Stock (191)
- Currency (127)
- Defense (75)
- Defensive Stocks (116)
- Dividend (512)
- Drug companies (276)
- Earnings (2938)
- Earnings Warning (447)
- Economy (2465)
- Editor's Picks (458)
- Emerging Markets (195)
- Entertainment (570)
- ETF (532)
- Exchange (43)
- Exchange News (121)
- FDA (90)
- Financial Stocks (1182)
- Food (592)
- General (3668)
- Green Biz (878)
- Alternative Energy (838)
- Hardware (207)
- Healthcare (173)
- HI/LOW (711)
- Housing (679)
- Index (288)
- Industry (157)
- Technology (117)
- Semiconductors (38)
- Technology (117)
- Infrastructure (197)
- Insider Activity (217)
- International Markets (2079)
- Internet (1720)
- Interview (53)
- IPOs (998)
- Labor & Unions (451)
- Large Cap Stocks (129)
- Law (404)
- Luxury (156)
- Management Change (629)
- Market Close (159)
- Market Open (191)
- Market Roundups (40)
- Media (861)
- Medical (238)
- Mergers and Buy Outs (1868)
- Metals (460)
- Micro Cap (7)
- Most Actives (31)
- Mutual Funds (224)
- Nanotech (8)
- Newsletter (7)
- Nuclear (74)
- Oil & Gas (1855)
- Old Media (206)
- Options (106)
- OTC (25)
- PC Companies (613)
- Personal Finance (79)
- Pharmaceuticals (227)
- Politics (567)
- Polls (23)
- Pre-Market Activity (757)
- Press Digest (1350)
- Private Equity (432)
- Product Review (62)
- Regulation (472)
- REIT (89)
- Research (1586)
- Restatements (23)
- Retail (1255)
- Rumors (876)
- Satellite (273)
- SEC (164)
- Secondary Offering (529)
- Semiconductor (638)
- Shareholder Issues (475)
- Short Interest (326)
- Small Cap Stocks (20)
- Software (766)
- Special Report (125)
- Stock Buybacks (173)
- Stock Splits (60)
- Tax (86)
- Technical Analysis (99)
- Technology Companies (1340)
- Telecom (657)
- The Day (84)
- The Week (148)
- Tobacco (47)
- Trading Alert (960)
- Transports (250)
- Turnarounds (210)
- TV (86)
- Utilities (283)
- Value Investing (330)
- Video Games (204)
- Water (55)
- WiMAX (164)
- Wireless (966)
